| Literature DB >> 35761007 |
Alexandra Teixeira1,2, Adriana Carneiro1,3, Paulina Piairo1, Miguel Xavier1, Alar Ainla1, Cláudia Lopes1, Maria Sousa-Silva1,4, Armando Dias1,4, Ana S Martins1,4, Carolina Rodrigues1,4, Ricardo Pereira1,4, Liliana R Pires5, Sara Abalde-Cela1, Lorena Diéguez6.
Abstract
In recent years, we have seen major advances in the field of liquid biopsy and its implementation in the clinic, mainly driven by breakthrough developments in the area of molecular biology. New developments have seen an integration of microfluidics and also biosensors in liquid biopsy systems, bringing advantages in terms of cost, sensitivity and automation. Without a doubt, the next decade will bring the clinical validation and approval of these combined solutions, which is expected to be crucial for the wide implementation of liquid biopsy systems in clinical routine.Entities:
Keywords: Cancer diagnosis; Liquid biopsy; Microfluidics; Personalized treatment; Precision medicine
Mesh：
Year: 2022 PMID： 35761007 DOI： 10.1007/978-3-031-04039-9_22
Source DB: PubMed Journal: Adv Exp Med Biol ISSN： 0065-2598 Impact factor: 3.650